IBM.LSE | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
Sales Analysis IBM
In the year ending in Jun 30,22, None sales were down 6.9% from $16.69 billion last year to $15.54 billion. We predict None sales to go down 8.6% to around $14.2 billion during the next 12 months. The share price of None has little sensitivity to increases to sales with forecast sales alone increasing the share price by 0.13%.
None currently has 0 employees and with sales of $15.54 billion this equates to sales of $inf, per employee.
For Jun 30,22 Cost of goods sold increased by 2.66% from last year's $7.06 billion to $7.25 billion this year. This is the 5 year in a row that it has increased, rising 8.52% from 2 years ago 's $6.68 billion. This cost represented 46.64% of overall sales up from 42.29% last year and is expected to fall to 45.55% next year. We predict Cost of goods sold to move down 10.8% to around $6.47 billion during the next 12 months.
Selling General and Administrative expenses were up 1.89% from $4.76 billion last year to $4.86 billion this year and we expect SGA to move down 17.6% to around $4.0 billion during the next 12 months.
This meant gross income was $8.29 billion making a gross profit margin of 53.36% of sales, which we expect to be 51.01% next year. The share price of None has little sensitivity to increases to gross profit margin.
With 0 employees, the gross income is $inf, per employee.
EBIT was 12.53% of sales and sharply decreased by 43.85% from last year's $3.47 billion to $1946.0 million this year and we expect EBIT to be $2.8 billion next year.
Pre-tax income was 11.08% of sales and, since last year, have fallen by 48.01%, from $3.31 billion to $1722.0 million this year and we expect it to be $2.57 billion next year. None paid $257.0 million tax. Its effective tax rate was 14.92% from 13.38% last year and estimated as 11.06% next year.
Including discontinued income, after tax income was 8.96% of sales and were down 48.63% from $2.71 billion last year to $1392.0 million this year and we expect it to be $2.21 billion next year. Return on Equity was unchanged since last year at inf, and we expect it to be 2.21 billion next year.